US FDA approves Roivant-Priovant's skin and muscle disease drug

The U.S. Food ‌and Drug Administration said on Thursday it approved a treatment from Roivant and ​partner Priovant Therapeutics for a ​rare disease, making it the ⁠first oral drug for the condition ​a...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。